Skip to main content
. 2018 Jun 4;2018(6):CD009642. doi: 10.1002/14651858.CD009642.pub3

3. Subgroup analyses ‐ type of surgery.

Main meta‐analyses Open abdominal surgery Laparoscopic surgery Other surgery Test for subgroup difference (P)
Outcome n Effect estimate
(I2)
n Effect estimate
(I2)
n Effect estimate
(I2)
Pain score, rest, 'early time points' (1 hr to 4 hrs, PACU) 8 −0.54 (−0.82 to −0.26)
(51%)
10 −0.78 (−1.34 to −0.21)
(89%)
11 −0.21 (−0.44 to 0.02)
(56%)
0.07
Pain score, rest, 'intermediate time points' (24 hrs) No subgroup analysis performed (I2 < 30%)  
Pain score, rest, 'late time points' (48 hrs) 7 0.03 (−0.17 to 0.23)
(0%)
7 −0.30 (−0.74 to 0.13)
(74%)
10 −0.10 (−0.27 to 0.08)
(20%)
0.35
Postoperative ileus (dichotomous) No subgroup analysis performed (I2 < 30%)  
Time to first defaecation/bowel movement (hrs) 6 −7.09 (−10.33 to −3.86)
(0%)
5 −6.23 (−18.07 to 5.62)
(85%)
1 −6.10 (−24.49 to 12.29)
NE
0.41
Time to first flatus (hrs) 6 −4.49 (−7.38 to −1.60)
(6%)
5 −3.07 (−8.28 to 2.15)
(78%)
2 −2.15 (−3.56 to −0.74)
(0%)
0.36
Time to first bowel sounds (hrs) 1 −10.00 (−17.13 to −2.87)
NE
1 −2.16 (−9.30 to 4.98)
NE
0 NE 0.13
Length of hospital stay (days) 6 −0.59 (−0.99 to −0.18)
(27%)
12 −0.15 (−0.58 to 0.28)
(77%)
14 −0.48 (−0.84 to −0.11)
(69%)
0.32
Length of hospital stay (outpatient surgery, mins) 0 NE 3 −10.81 (−36.93 to 15.31) 0 NE NE
Surgical complications ‐ anastomotic leak No subgroup analysis performed (I2 < 30%)  
Surgical complications ‐ bleeding No subgroup analysis performed (I2 < 30%)  
Surgical complications ‐ postoperative infection No subgroup analysis performed (I2 < 30%)  
Patient satisfaction No subgroup analysis performed (I2 < 30%)  
Postoperative nausea, early (PACU) No subgroup analysis performed (I2 < 30%)  
Postoperative nausea, overall (0 to 24 hrs, to 48 hrs, to 72 hrs) No subgroup analysis performed (I2 < 30%)  
Postoperative vomiting, early (PACU) No subgroup analysis performed (I2 < 30%)  
Postoperative vomiting, overall (0 to 24 hrs, to 48 hrs, to 72 hrs) No subgroup analysis performed (I2 < 30%)  
Intraoperative opioid consumption (MEQ, mg) 7 −1.93 (‐4.61 to 0.75)
(78%)
3 −0.71 (−7.95 to 6.53)
(93%)
8 −2.03 (−4.14 to 0.07)
(40%)
0.94
Intraoperative opioid consumption with remifentanil (MEQ, mg) No subgroup analysis performed (I2 < 30%)  
Postoperative opioid consumption, PACU (MEQ, mg) 5 −3.03 (−4.82 to −1.23)
(0%)
7 −3.84 (−4.57 to −3.11)
(0%)
9 −2.66 (−4.19 to −1.13)
(61%)
0.33
Postoperative opioid consumption, overall (MEQ, mg) 11 −3.56 (−6.76 to −0.35)
(40%)
16 −4.85 (−7.46 to −2.23)
(77%)
13 −5.54 (−9.35 to −1.72)
(77%)
0.71

Acronyms and abbrviations used in this table:

hrs = hours, MEQ = morphine equivalent dose, mins = minutes, NE = not estimable, PACU =post anaesthesia care unit